UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Medline ® Abstract for Reference 74

of 'Clinical features, diagnosis, and management of von Hippel-Lindau disease'

74
TI
Aggressive papillary tumor of middle ear/temporal bone and adnexal papillary cystadenoma. Manifestations of von Hippel-Lindau disease.
AU
Gaffey MJ, Mills SE, Boyd JC
SO
Am J Surg Pathol. 1994;18(12):1254.
 
The occurrence of an aggressive papillary middle ear/temporal bone tumor (APMET) and a benign adnexal papillary tumor of probable mesonephric origin (APMO) in a patient with von Hippel-Lindau disease (VHL) is reported. Histologically, both tumors were identical to papillary cystadenomas of the epididymis and broad ligament of probable mesonephric derivation. A comprehensive literature review showed that including the current case, seven of 46 (15%) documented cases of APMET and four of four (100%) cases of APMO arose in patients with VHL. Given an estimated minimum birth incidence of 1/36,000, a one-sample test of binomial proportion using the exact method establishes that the association of APMET and APMO with VHL is highly significant (p = 1.4 x 10(-24) and 1 x 10(-18), respectively). The data indicate that APMET and APMO may represent major visceral manifestations of VHL. Accordingly, in the presence of one of these tumors strong consideration should be given to the diagnosis of VHL, given either the presence of another major component of VHL or documentation of VHL in at least one consanguineous relative.
AD
Division of Anatomic Pathology, University of Virginia Health Sciences Center, Charlottesville 22908.
PMID